CB Insights Unveils Industry's First AI Agent Workforce for M&A, Partnerships, Competitive Intelligence, Deal Sourcing, GTM, and More
Article content
NEW YORK — CB Insights, the leading provider of predictive market intelligence, today announced the launch of its Team of Agents – the industry's first comprehensive AI agent workforce designed specifically to enable business leaders with always-on market intelligence for strategic decision-making. CB Insights' growing team of agents starts with 11 specialized agents that work continuously to uncover insights, translate proprietary data into action, and accelerate smart decisions by providing the external intelligence layer that enterprises need to compete effectively across business development, investments, partnerships, GTM, and competitive intelligence.
Article content
While generic AI assistants struggle with business context and lack reliable external data, CB Insights' Team of Agents delivers validated intelligence and data science on over 10 million companies and 1,500 tech markets through purpose-built specialists that understand the nuanced requirements of strategic business functions.
Article content
Enterprise clients are already hiring CB Insights' Team of Agents to streamline their workflows and accelerate decision-making across research, diligence, briefings, and more – saving months of work.
Article content
'The Scouting Report Agent is amazing – it's a huge time saver and lets us respond quickly with enough insight to get back to a client or be dangerous with,' said Bethany Boutin, Business & Market Intelligence Lead: Commercial Solutions + Digital at Evernorth Health Services, a subsidiary of The Cigna Group.
Article content
'Most AI agents today are generalists trying to do everything – but when it comes to strategic decisions, you need specialists who understand your business context and have access to reliable external intelligence,' said Manlio Carrelli, CEO of CB Insights. 'Our Team of Agents represents the evolution from generic AI assistants to purpose-built intelligence operatives. They work around the clock on your behalf, each one an expert in their domain, all powered by our double-verified Business Graph and data science on the world's companies and markets – insights and data that are not available on ChatGPT, the Internet, or in any other agent.'
Article content
While most enterprise strategic decisions require external market intelligence about competitors, markets, and potential partners, existing AI tools often lack the specialized context and validated data necessary for high-stakes business decisions. CB Insights' growing Team of Agents solves this, starting with 11 specialized agents that deliver:
Article content
The agents listed are not exhaustive and CB Insights' clients can create their own with Microsoft Copilot, MCP, and soon directly in ChatCBI.
Article content
Agents Powered by the World's Most Comprehensive Business Graph
Article content
Unlike AI agents that rely on public web data or limited datasets, CB Insights' Team of Agents operates on the proprietary Business Graph – a continuously validated dataset with patented data science covering management teams, funding rounds, partnerships, deals, earnings calls, hiring patterns, patents, and more across global business activity.
Article content
'The quality of AI output depends entirely on the quality of data input,' said Carrelli. 'Our agents don't just scrape the web – they work with double-verified intelligence based on proprietary information collected from companies and their customers directly, unique datasets like their commercial relationships, and proprietary data science that scores future potential. This means when our Competitive Sentinel tells you a rival is planning a major acquisition, or when our Acquisition Hunter identifies a strategic target, you can make decisions with confidence.'
Article content
Designed for Enterprise Integration
Article content
The Team of Agents operates across multiple platforms where strategic work happens:
Article content
Native integration with CB Insights' Strategy Terminal for comprehensive market intelligence workflows
Microsoft 365 Copilot integration for seamless incorporation into existing productivity tools
Model Context Protocol (MCP) compatibility for any MCP-compatible AI agent to tap into CB Insights' datasets and tools – including ChatCBI – without a single line of code
API and custom solutions for embedding intelligence into enterprise applications and workflows
CB Insights' forward-deployed strategists work with you to automate your research and strategy flows with custom agents
Article content
'We're not asking enterprises to change how they work – we're making their existing workflows dramatically more intelligent,' said Carrelli. 'Whether you're in Excel building a market model, in PowerPoint preparing for a board meeting, or doing deep work inside the CB Insights terminal, our agents provide the external intelligence you need exactly when and where you need it.'
Article content
Availability and Pricing
Article content
CB Insights' Team of Agents is available immediately to enterprise customers through flexible deployment options. Individual agents can be deployed for specific use cases, or enterprises can access the full team for comprehensive market intelligence automation.
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Tmc The Metals Company: Wedbush Raises Valuation on Optimism
TMC The Metals Company (TMC) (About (STA Research): Is a Canadian investment research company, consisting of Financial Professionals specializing in advanced stock research and analysis) Wedbush raised their 12 month target price for The Metals Company Inc. from $6 to $11, reflecting a significantly more optimistic view of the company's future. This upward revision is driven by several key factors. First, the recent executive order supporting critical mineral development has bolstered confidence in the regulatory environment, providing a favorable backdrop for the company's deep sea mining operations. Second, The Metals Company has strengthened its balance sheet, improving its financial stability and ability to fund ongoing and future projects. Lastly, there is growing momentum around U.S.-backed initiatives focused on deep sea mining, positioning the company at the forefront of a strategic sector vital to the country's resource independence and clean energy transition. Collectively, these developments enhance the company's long-term growth prospects and justify the more aggressive price target. Stock Forecast & Analysis Analyst sentiment toward The Metals Company (TMC) is cautiously optimistic, with a consensus 'Buy' rating and as 12 month target price forecast of $9 per share. While TMC has strengthened its financial position with $81 million in cash and progress on key permits, it remains a pre-revenue company with projected losses and significant capital needs through 2027. Growth forecasts are strong—around 64% annual earnings growth and over 100% revenue growth—but investors face risks such as regulatory delays, high production costs, and environmental concerns. Overall, while deep-sea mining has strategic backing, it remains a speculative and volatile investment.
Globe and Mail
2 hours ago
- Globe and Mail
How new grads should be approaching AI as they seek careers in finance
School's out, grads are looking for jobs, and there aren't many to be had. So, why are young job-seekers optimistic about their prospects in finance? According to the CFA Institute's global graduate outlook survey, 40 per cent of Canadian university students and recent grads ranked finance as the sector in which they have the most confidence, beating the next closest sector – STEM (science, technology, engineering, and mathematics) – by 20 percentage points. What gives? Michael Thom, managing director of CFA Societies Canada, says the financial sector may offer better prospects for young professionals with artificial intelligence skills they're ready to use in the workplace. Most students (87 per cent) surveyed expressed confidence in their AI literacy, and 35 per cent believed their AI skills would boost their job prospects more than traditional skills, such as speaking another language, at 23 per cent. Still, almost three-quarters feared AI could hurt their careers and make it harder to get a job. We spoke with Mr. Thom about the survey and what's most important for those entering careers in finance. New grads like the financial industry right now. How come? I wish I had [more] explanatory variables. If you look at some of the questions around secular challenges, there's a pathway in which finance is enabled by AI and able to adapt to the challenge of AI, and it's not entirely disrupted and made obsolete. Unfortunately, it's a dire market for new grads, and AI may be contributing with entry-level jobs being eliminated. How should grads be looking at that in terms of financial jobs in Canada? The younger cohort is definitely affected inordinately by the employment weakness we're seeing in the broader Canadian economy right now, and that's a point of concern. I'd want to look at what the data points are on financial services on a sectoral basis, but it's in the data that new grads are positive, and I think financial services is going to be relatively resilient in this cycle. And that's cause for optimism. What new skills should people entering finance be acquiring or developing? That's been a big topic of conversation. AI literacy is something that probably a certain number of the new grad cohort take for granted, but it's really important to turn whatever implicit literacy you have into applicable skills in the workplace. So, arming yourself with understanding AI, and generative AI in particular, [as well as] broader trends around data usage and data wrangling … and synthesizing that into parts of your job. There's reason to think about AI as an enabler rather than a replacer, at least at this stage. What are some of the ways entry-level jobs in the financial sector are changing as AI is adopted? Some of the pieces of relatively low value-add work around rote commentary and content production – tasks junior staff would have cut their teeth on just as a learning exercise. That's compressing, to some degree, where there are pieces in that value chain that generative AI is quite competent at if prompted properly, fed the right information properly, and constrained from a hallucination perspective properly. And then it allows you to scale the outputs really interestingly. UBS has deployed AI personas of some of their analysts to answer questions on the basis of their published research, allowing them to stretch further from both an internal and an external client resourcing perspective. That's really interesting as a not-so-remote application. That's enablement as opposed to replacement, and allowing highly trained investment professionals at various levels of their career development to be in more places at once, which is exciting. In terms of replacement, is there any risk that if firms aren't needing to hire as many entry-level positions – whether it's analysts or advisor assistants – that you lose out on the talent chain and it's tougher to have that pipeline, especially on the advisor side, as the industry ages? It's a risk, but you really have to look at this on a sector-relative basis. AI allows new hires to get to more value-added work more quickly, and take away some of those low value-added tasks. So, from a progress perspective, there's more progress expected more quickly from staff to provide value around tasks that AI can't do reliably, better and more quickly. Again, that's exciting from a career development perspective. Does it have net negative effects on the number of people you need to hire? Maybe, but I'm not convinced by anything I've seen yet that it's affecting finance more than elsewhere. If anything, it might be the inverse. Is there anything else you want to say on this? There's still this view in some quarters that this is a hype cycle: 'I don't believe this is real yet, and I don't think this justifies changing my skill set and how I do my job.' And that might be ill-founded. AI does deserve everyone's attention. Whether you're late career, mid career, or early career, you're probably going to want to approach it in different ways, but it's worth everyone's attention. - This interview has been edited and condensed. Insurance changes: Danielle Kanengoni, the president of Allan Financial in Vancouver, has had her licence to work as a life insurance advisor in British Columbia for more than a decade. But in Quebec, the mid-career professional still had to be supervised by another advisor for three months this spring to obtain her licence in that province. It's one example of the friction life insurance advisors say exists for those who want to work with clients in multiple provinces. Tax changes: Bill C-4, the Liberal government's legislation to reduce the tax rate for the lowest federal tax bracket, is still making its way through Parliament. While this change will result in tax savings for many Canadians, not everyone will receive the same benefit. In some situations, this change could increase taxes payable, writes Aaron Hector. Advice changes: CIRO is looking at allowing order-execution-only dealers to provide non-tailored advice to clients to address the growth of the do-it-yourself investment landscape. What would this mean for investors? Kelsey Rolfe reports. A big retirement: The formula for success in personal finance is just this: Spend less than you make, keep debt manageable and save and invest regularly, writes Rob Carrick. In his final column as The Globe and Mail's personal finance columnist, Mr. Carrick offers solutions to some of the challenges people face in managing their money. Two big mistakes: The founders of Burgundy Asset Management Ltd. never wanted to sell the business they built over 35 years to a bank. But management made two strategic mistakes that cost the firm its independence, leading to its $625-million sale to BMO, writes Andrew Willis, offering lessons in succession to any entrepreneur-owned businesses. A big scam: Last week, Bank of Montreal chief investment strategist Brian Belski became the latest finance heavyweight to warn his social media followers about imposters posing as him to scam investors. While scams impersonating celebrities and politicians have proliferated for years, fraud targeting investors through fake advice from big names in finance is now multiplying, with the real experts struggling to get the content taken down.
Globe and Mail
2 hours ago
- Globe and Mail
Analyst Coverage Updates
Analyst Ratings-USA June 26th, 2025 Analysts collectively signal a bullish market with growth opportunities, showing confidence in strong corporate earnings, growth potential, and improving economic conditions, while recommending caution in select areas. This outlook suggests investors might consider being invested but remain watchful for risks or volatility. Analyst Coverage Updates: Company Name Symbol Action Investment Bank Analyst Rating Target Price A. O. Smith Corporation AOS Target Update UBS Hold $74.00 Abercrombie Fitch ANF Target Update UBS Buy $130.00 Abivax SA Sponsored ADR ABVX Target Update LifeSci Capital Buy $45.00 Acuity Brands AYI Target Update TD Cowen Buy $330.00 Advance Auto Parts AAP Target Update Evercore ISI Hold $52.00 AFLAC AFL Target Update TD Cowen Hold $100.00 Aldeyra Therapeutics ALDX Target Update JonesTrading Buy $6.00 Alphabet Class A GOOGL Target Update RBC Capital Buy $200.00 Altimmune ALT Target Update Financial Buy $20.00 Altimmune ALT Target Update H.C. Wainwright Buy $12.00 Amarin AMRN Target Update Goldman Sachs Sell $12.00 Amazon AMZN Target Update Exane BNP Paribas Buy $254.00 Amazon AMZN Target Update Bank of America Securities Buy $248.00 Ambarella AMBA Target Update Rosenblatt Securities Buy $95.00 Ambarella AMBA Target Update Stifel Nicolaus Buy $80.00 Arcturus Therapeutics ARCT Target Update Scotiabank Buy $32.00 Array Technologies ARRY Target Update Goldman Sachs Buy $11.00 ArriVent BioPharma, Inc. AVBP Target Update Clear Street Buy $32.00 aTyr Pharma ATYR Target Update Leerink Partners Buy $16.00 Autoliv ALV Target Update Morgan Stanley Hold $117.60 Baker Hughes Company BKR Target Update Jefferies Buy $52.00 Beam Therapeutics BEAM Target Update J.P. Morgan Buy $48.00 Holdings BILL Target Update KBW Hold $54.00 Biogen BIIB Target Update RBC Capital Buy $213.00 Blackstone Group BX Target Update TD Cowen Buy $196 Capricor Therapeutics CAPR Target Update JonesTrading Buy $29 Carnival CCL Target Update J.P. Morgan Buy $34.00 Carnival CCL Target Update Mizuho Securities Buy $35.00 Carnival CCL Target Update Goldman Sachs Buy $33.00 Cheniere Energy LNG Target Update Bank of America Securities Buy $271.00 Cheniere Energy Partners CQP Target Update Bank of America Securities Sell $53.00 Chevron CVX Target Update RBC Capital Buy $175.00 Cibus CBUS Target Update Canaccord Genuity Buy $15.00 Circle Internet Group, Inc. Class A CRCL Target Update US Tiger Securities Hold $200.00 Citigroup C Target Update Truist Financial Buy $84 Cogent Biosciences COGT Target Update Piper Sandler Buy $24.00 Coinbase Global COIN Target Update Citizens JMP Buy $400.00 Comcast CMCSA Target Update Benchmark Co. Buy $48.00 Commercial Metals Company CMC Target Update UBS Hold $48.00 Constellation Brands STZ Target Update Needham Buy $195 Constellation Brands STZ Target Update UBS Buy $195.00 Corebridge Financial, Inc. CRBG Target Update Evercore ISI Buy $39.00 Corvus Pharmaceuticals CRVS Target Update Mizuho Securities Buy $11.00 Crescent Biopharma CBIO Target Update Stifel Nicolaus Buy $28.00 Crispr Therapeutics AG CRSP Target Update Goldman Sachs Hold $47.00 CSX CSX Target Update BMO Capital Buy $36.00 Darden Restaurants DRI Target Update Stifel Nicolaus Buy $245.00 Delcath Systems DCTH Target Update Canaccord Genuity Buy $21 Dexcom DXCM Target Update Oppenheimer Buy $95.00 DHI Group DHX Target Update Barrington Buy $11.50 Dollar Tree DLTR Target Update Evercore ISI Hold $94.00 DTE Energy DTE Target Update UBS Buy $148.00 Duolingo DUOL Target Update D.A. Davidson Buy $500.00 Eli Lilly & Co LLY Target Update TD Cowen Buy $960.00 EMCOR Group EME Target Update Robert W. Baird Buy $560.00 EPR Properties EPR Target Update Stifel Nicolaus Buy $65.00 Equinix EQIX Target Update Citi Buy $990.00 Etsy ETSY Target Update Truist Financial Buy $60.00 Eversource Energy ES Target Update Mizuho Securities Buy $72.00 Exelixis EXEL Target Update Jefferies Buy $50.00 Exxon Mobil XOM Target Update RBC Capital Hold $105.00 Factset Research FDS Target Update UBS Hold $480.00 FedEx FDX Target Update Susquehanna Buy $295.00 FedEx FDX Target Update Raymond James Buy $260.00 FedEx FDX Target Update Truist Financial Buy $275.00 Flowco Holdings Inc Class A FLOC Target Update Jefferies Buy $32.00 Flowserve FLS Target Update Jefferies Buy $65.00 Franklin Covey Company FC Target Update Barrington Buy $35.00 Gain Therapeutics GANX Target Update Scotiabank Buy $12.00 General Dynamics GD Target Update TD Cowen Buy $300.00 General Mills GIS Target Update Bernstein Hold $55.00 General Mills GIS Target Update Evercore ISI Hold $54.00 Gitlab GTLB Target Update Goldman Sachs Hold $50.00 Glacier Bancorp GBCI Target Update Piper Sandler Hold $47 GMS GMS Target Update Truist Financial Hold $105.00 Gold Fields GFI Target Update RBC Capital Buy $32.00 Guidewire GWRE Target Update J.P. Morgan Buy $288.00 Gyre Therapeutics GYRE Target Update Stifel Nicolaus Buy $28.00 H.B. Fuller Company FUL Target Update Citi Hold $62.00 Health In Tech, Inc. Class A HIT Target Update Maxim Group Buy $2.50 Heidrick & Struggles HSII Target Update Truist Financial Hold $46.00 Helmerich & Payne HP Target Update RBC Capital Hold $23.00 Hess HES Target Update UBS Buy $173.00 Hub Group HUBG Target Update BMO Capital Hold $38.00 Humana HUM Target Update Truist Financial Hold $280.00 I-MAB IMAB Target Update H.C. Wainwright Buy $7.00 Idexx Laboratories IDXX Target Update Leerink Partners Buy $580.00 Immuneering IMRX Target Update Jefferies Hold $3.50 International Paper Co IP Target Update Truist Financial Buy $59.00 Intuit INTU Target Update Citi Buy $789.00 Jack In The Box JACK Target Update Stifel Nicolaus Hold $20.00 JB Hunt JBHT Target Update BMO Capital Buy $172.00 KalVista Pharmaceuticals KALV Target Update Stifel Nicolaus Buy $39.00 KalVista Pharmaceuticals KALV Target Update JonesTrading Buy $30.00 Kennametal KMT Target Update Loop Capital Markets Hold $24.00 Keurig Dr Pepper KDP Target Update UBS Buy $42.00 Korn Ferry KFY Target Update Truist Financial Buy $88.00 Kratos Defense KTOS Target Update Truist Financial Buy $52.00 Krispy Kreme DNUT Target Update Truist Financial Hold $5.00 Kroger Company KR Target Update Northcoast Research Buy $80.00 Krystal Biotech KRYS Target Update TD Cowen Buy $202.00 Liberty Media Liberty Formula One FWONK Target Update Susquehanna Buy $121.00 Louisiana-Pacific LPX Target Update D.A. Davidson Buy $117.00 Lucky Strike Entertainment LUCK Target Update Stifel Nicolaus Buy $12.00 Lyft LYFT Target Update Canaccord Genuity Hold $14.00 McCormick & Company MKC Target Update Jefferies Buy $90.00 McCormick & Company MKC Target Update UBS Hold $83.00 Meta Platforms META Target Update RBC Capital Buy $740.00 Microchip MCHP Target Update Truist Financial Hold $64.00 Micron MU Target Update CFRA Buy $155.00 Microsoft MSFT Target Update Wedbush Buy $600.00 Molecular Partners MOLN Target Update LifeSci Capital Buy $12.00 Napco Security Technologies NSSC Target Update D.A. Davidson Buy $33.00 National Cinemedia NCMI Target Update Benchmark Co. Buy $7 Nektar Therapeutics NKTR Target Update H.C. Wainwright Buy $120.00 Nektar Therapeutics NKTR Target Update BTIG Buy $100.00 Nektar Therapeutics NKTR Target Update Piper Sandler Buy $105.00 NeuroPace NPCE Target Update Leerink Partners Buy $17.00 Newmont Mining NEM Target Update National Bank Hold $100.00 Nexstar Media Group NXST Target Update Guggenheim Buy $220.00 Nextdoor Holdings KIND Target Update Financial Hold $2.00 Nike NKE Target Update RBC Capital Hold $65.00 Norfolk Southern NSC Target Update BMO Capital Hold $270.00 Nurix Therapeutics NRIX Target Update Oppenheimer Buy $32.00 Nuvalent NUVL Target Update UBS Buy $114.00 Nuvalent NUVL Target Update Robert W. Baird Buy $112.00 Nuvation Bio NUVB Target Update Citizens JMP Buy $6.00 Nvidia NVDA Target Update Loop Capital Markets Buy $250 Old Dominion Freight ODFL Target Update BMO Capital Hold $172.00 OnKure Therapeutics OKUR Target Update LifeSci Capital Buy $20.00 Option Care Health OPCH Target Update UBS Buy $40.00 Packaging PKG Target Update Truist Financial Buy $239.00 Patterson-UTI PTEN Target Update RBC Capital Buy $9.00 Paychex PAYX Target Update Morgan Stanley Hold $148.00 Paylocity PCTY Target Update TD Cowen Buy $227.86 PennyMac Financial PFSI Target Update BTIG Buy $135.00 Phibro Animal Health PAHC Target Update Morgan Stanley Hold $26.00 Plymouth Industrial Reit PLYM Target Update Colliers Securities Buy $19.50 Postal Realty PSTL Target Update Stifel Nicolaus Buy $18.25 Real Brokerage REAX Target Update Financial Buy $7 Reddit Inc Class A RDDT Target Update RBC Capital Hold $125.00 Revolution Medicines RVMD Target Update Needham Buy $57.00 RH RH Target Update Goldman Sachs Sell $179.00 Rivian Automotive RIVN Target Update Mizuho Securities Hold $13.00 RXO, Inc. RXO Target Update TD Cowen Hold $15.00 Samsara IOT Target Update Truist Financial Hold $42.00 Samsara IOT Target Update Loop Capital Markets Buy $50.00 Samsara IOT Target Update TD Cowen Buy $51.00 Samsara IOT Target Update Piper Sandler Buy $53.00 Samsara IOT Target Update RBC Capital Buy $54.00 Sangamo Biosciences SGMO Target Update H.C. Wainwright Buy $10.00 ServiceNow NOW Target Update D.A. Davidson Buy 1,150.00 Sirius XM Holdings SIRI Target Update J.P. Morgan Sell $20.00 SL Green Realty SLG Target Update Piper Sandler Buy $72.00 Spotify SPOT Target Update Bank of America Securities Buy $900.00 Sun Communities SUI Target Update Deutsche Bank Hold $135.00 Surgery Partners SGRY Target Update UBS Buy $34.00 Talos Energy TALO Target Update Roth MKM Buy $11.00 TD SYNNEX Corporation SNX Target Update Barclays Hold $140.00 TD SYNNEX Corporation SNX Target Update UBS Buy $154.00 Telecom Argentina TEO Target Update J.P. Morgan Hold $11.00 Tesla TSLA Target Update RBC Capital Buy $307.00 Texas Instruments TXN Target Update TD Cowen Hold $200.00 The Estée Lauder Companies EL Target Update HSBC Buy $69.67 Theravance Biopharma TBPH Target Update BTIG Buy $25.00 Theravance Biopharma TBPH Target Update JonesTrading Buy $24.00 TMC the metals company TMC Target Update Wedbush Buy $11.00 Uber Technologies UBER Target Update Canaccord Genuity Hold $84.00 UMB Financial UMBF Target Update Piper Sandler Buy $135.00 Union Pacific UNP Target Update BMO Capital Buy $270.00 UnitedHealth UNH Target Update UBS Buy $385.00 Venture Global, Inc. VG Target Update Bank of America Securities Buy $18.50 Veradigm MDRX Target Update TD Cowen Buy $8.00 Verastem VSTM Target Update RBC Capital Buy $12.00 Verizon VZ Target Update Exane BNP Paribas Buy $51.00 Verve Therapeutics VERV Target Update BMO Capital Hold $13.50 VNET Group, Inc. Sponsored ADR VNET Target Update Bank of America Securities Buy $11.30 Vor Biopharma VOR Target Update Robert W. Baird Hold $1.00 Vor Biopharma VOR Target Update Stifel Nicolaus Hold $0.30 VSE VSEC Target Update Jefferies Buy $157.00 Walgreens Boots Alliance WBA Target Update Evercore ISI Hold $11.45 Waste Management WM Target Update Oppenheimer Buy $255.00 Watsco WSO Target Update UBS Hold $450.00 Wells Fargo WFC Target Update Morgan Stanley Buy $87.00 Westlake Corporation WLK Target Update Alembic Global Buy $100.00 Winnebago Industries WGO Target Update Roth MKM Hold $37.00 Workiva WK Target Update Robert W. Baird Buy $105.00 XPO XPO Target Update TD Cowen Buy $133.00 XPO XPO Target Update BMO Capital Buy $146.00 Zimmer Biomet Holdings ZBH Target Update BTIG Buy $117
